Mya Tran

@MyaPrecisionG

Precision Genomics Oncology Pharmacist, PharmD, BCOP, Indiana University Health - Simon Comprehensive Cancer Center

Indianapolis, IN

Joined February 2024

228Following

144Followers

Pinned

Mya Tran@MyaPrecisionG · Nov 10

50 years.. and countless lives saved! Dr. Einhorn - we’re so grateful for you ♥️ #TesticularCancerCure #ResearchCureCancer @IUCancerCenter

MyaPrecisionG's tweet image. 50 years.. and countless lives saved!
Dr. Einhorn - we’re so grateful for you ♥️ #TesticularCancerCure #ResearchCureCancer @IUCancerCenter

2.0K

Mya Tran Retweeted

Eric Topol@EricTopol · Jul 18

What are "omics"? A good schematic cell.com/neuron/fulltex… could add epigenomics, immunomics, microbiomics, glycomics, exposomics, etc

231

850

398

82.0K

Mya Tran@MyaPrecisionG · Jul 12

#PrecisionMed 2025- Dr. Schneider discussed Clinical Utility at IU ASCO25 Review #ASCO25 ✅ Many targets w real activity ➡️ enroll pts on trials! (KRAS, MTAP etc) ✅AI assisted path (TROP2 NMR) ❌ctDNA MRD/dynamics: ?OS ❌MCED: suboptimal LOD for agnostic approach More 2 come!

MyaPrecisionG's tweet image. #PrecisionMed 2025- Dr. Schneider discussed Clinical Utility at IU ASCO25 Review #ASCO25
✅ Many targets w real activity ➡️ enroll pts on trials! (KRAS, MTAP etc)
✅AI assisted path (TROP2 NMR)
❌ctDNA MRD/dynamics: ?OS
❌MCED: suboptimal LOD for agnostic approach
More 2 come!

409

Mya Tran Retweeted

Misty Dawn Shields@drshieldsmd · Jul 12

A friendly, funny, and fierce debate on the timing of IO for resectable NSCLC: ⭐️neoadj @gdurm vs ⭐️periop @RManiarMD vs ⭐️adjuvant @drshieldsmd Never a dull moment at a IU @ASCO Debate! 🏀 @IUCancerCenter #ASCO25 @Pacers @dallasmavs @nyknicks

1.0K

Mya Tran Retweeted

Misty Dawn Shields@drshieldsmd · Jul 12

Fantastic keynote fireside chat with 2024-2025 ASCO President Dr. Robin Zon (@ASCO) & @nabiladra at the @IUCancerCenter #ASCOReview25 on access, knowledge, and support to drive knowledge to action to build a better future for our patients and their families facing cancer.

1.0K

Mya Tran Retweeted

JCO Precision Oncology@JCOPO_ASCO · Jul 11

Fidelity of Next-Generation Sequencing to Predict Human Epidermal Growth Factor 2 Overexpression Across Solid Tumors. Co-authored by @MyaPrecisionG. Read full article. brnw.ch/21wU4vg

538

Mya Tran Retweeted

Stephen V Liu, MD@StephenVLiu · Jul 4

Analysis of MARIPOSA @JTOonline comparing 1L lazertinib and osimertinib in #EGFR NSCLC. PFS 18.5m with lazertinib vs 16.6m with osimertinib (HR 0.98), RR 83% vs 85%, DOR 16.6m vs 16.8m, OS HR 1.00 - similar tox (laz more rash, osi more diarrhea). jto.org/article/S1556-…

4.0K

Mya Tran Retweeted

Ming "Tommy" Tang@tangming2005 · Jun 20

A first-in-class EGFR-directed KRAS G12V selective inhibitor cell.com/cancer-cell/fu…

3.0K

Mya Tran Retweeted

ESMO Open@ESMO_Open · Jun 20

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma in @ESMO_Open. Actionable targets in 46% of STS, specific subgroups with higher prevalence. WGS-informed therapy in 14% of cases. esmoopen.com/article/S2059-…

5.0K

Mya Tran Retweeted

Ming "Tommy" Tang@tangming2005 · Jun 6

Why are there intronic reads in your bulk RNA-seq data? You're not alone—it's common, and the reasons are more layered than you think. Let’s break it down. 🧵

300

286

39.0K

Mya Tran@MyaPrecisionG · May 30

WGS strikes again! enable MRD detection at ultra sensitive level, overcoming LoD ~100ppm of WES ➡️ ctDNA clearance during NAC 👉🏻 pCR Many❓remain: tissue requirement? how to account for tumor evolution? role of incorporating other markers? #ctDNA #ASCO2025

MyaPrecisionG's tweet image. WGS strikes again! enable MRD detection at ultra sensitive level, overcoming LoD ~100ppm of WES
➡️ ctDNA clearance during NAC 👉🏻 pCR
Many❓remain: tissue requirement? how to account for tumor evolution? role of incorporating other markers? #ctDNA #ASCO2025

176

Mya Tran Retweeted

Ferdinandos Skoulidis@FSkoulidis · May 28

Thrilled to share this exciting study ⁦@NatureMedicine⁩. Largest integrative analysis of #sotorasib efficacy biomarkers to date. Grateful to all co- investigators and the Amgen team for their hard work and most of all to our patients. ⁦@MDAndersonNews⁩ #KRAS #NSCLC

198

20.0K

Mya Tran@MyaPrecisionG · May 25

Incredibly honored to be a recipient of a @ConquerCancerFd Career Development Award for our biomarker research in #SCLC. Forever grateful to mentors @hannawants2ELCN @christine_lovly & fierce pt advocate @jillfeldman4 for your guidance & support! @IUCancerCenter @SclcSMASHERS

CConquer Cancer, the ASCO Foundation@ConquerCancerFd · May 22

Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A @ASCO

4.0K

Mya Tran@MyaPrecisionG · May 24

Good luck Katie!!!! You got this ♥️🔥@ktgminton #smartie 🔬👩‍⚕️ 🏥

MMisty Dawn Shields@drshieldsmd · May 24

There are no words to express how incredibly PROUD I am of our @TheShieldsLab expert level tech, Katie Minton @ktgminton. Katie has been instrumental 🔑 as a leader in our lab’s 🥼 research on #SCLC from day 1️⃣! We wish Katie ALL THE BEST as she begins her MD PhD @IUMedSchool!

216

Mya Tran Retweeted

Stephen V Liu, MD@StephenVLiu · May 12

Early data on lazertinib in uncommon #EGFR mutant NSCLC @JTOonline. In 36 pts, RR 50% with mPFS 10.8m, mDOR 15.1m. By mutation, G719X RR 61%, S768I RR 60%, L861Q RR 58%. jto.org/article/S1556-…

4.0K

Mya Tran Retweeted

ESMO Open@ESMO_Open · May 2

Precision oncology in biliary tract cancer: the emerging role of liquid biopsy in @ESMO_Open. Complete review on liquid biopsy in BTC: from different sources and techniques to specific clinical scenarios towards personalized medicine. esmoopen.com/action/showPdf…

5.0K

Mya Tran@MyaPrecisionG · Apr 29

Now lets compare Zongertinib with one more Oral TKI in Same space. ( BAY2927088 ) We are in era of Exciting new drugs. Hopefully they will keep their promises in larger data sets also. @OncBrothers @OncoAlert @AACR

DDr Amol Akhade@SuyogCancer · Apr 28

New HER2 Targeted Therapy Alert! 🧬 Zongertinib (BI 1810631) = Game-changer? ✅ 71% ORR ✅ 12.4 mo PFS ✅ Active in brain metastases ✅ No ILD ❌ ✅ EGFR-sparing ➔ Less rash, diarrhea! ⚡ Direct comparison vs trastuzumab deruxtecan! ⚡ Clinical MoA snapshot included! Swipe ➡️…

4.0K

Mya Tran Retweeted

ACS Journal Cancer@JournalCancer · Apr 25

#AACR25 will feature breakthroughs in cancer science & medicine. It's a perfect time to peruse recent work examining 2024 treatment advances in small-cell lung cancer. See @drshieldsmd's video summary below & access the commentary acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @LUNGevity

3.0K

Mya Tran Retweeted

Stephen V Liu, MD@StephenVLiu · Apr 21

Congratulations to lung cancer advocate @chrisdraft who will receive the 2025 Marv Levy Impact Award on May 30 at the 2025 @Gridiron_Greats Hall of Fame in Chicago, IL! One of the most positive people I have ever met and deserving of every accolade. gridirongreats.org/halloffame

5.0K